Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

NCT02726074 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eisai Korea Inc.